Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas
Condition(s):Neurofibromatosis 1Last Updated:November 7, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Neurofibromatosis 1Last Updated:November 7, 2023Recruiting
Condition(s):Neurofibromas, Cutaneous; Neurofibromatosis 1Last Updated:March 8, 2024Not yet recruiting
Condition(s):Neurofibromatosis 1Last Updated:February 9, 2024Recruiting
Condition(s):Barrett Esophagus; Esophageal AdenocarcinomaLast Updated:August 30, 2023Recruiting
Condition(s):Amyotrophic Lateral SclerosisLast Updated:March 3, 2023Recruiting
Condition(s):Microbiota; CancerLast Updated:February 20, 2024Recruiting
Condition(s):Microtia; Dysbiosis; Alcohol Drinking; HIV Infections; Cardiovascular DiseasesLast Updated:September 21, 2023Recruiting
Condition(s):Cystic Fibrosis; Liver Fibrosis; Gastrointestinal Transport Disorder; DiosLast Updated:October 23, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.